DHINGRA KAPIL,HIGGINS BRIAN,KOLINSKY KENNETH,LEE RICHARD J.,LESTINI BRIAN,PACKMAN KATHRYN E.,SU FEI,DHINGRA Kapil,HIGGINS Brian,KOLINSKY Kenneth,LEE Richard J.,LESTINI Brian,PACKMAN Kathryn E.,SU Fei
申请号：
SI201130486
公开号：
SI2605764T1
申请日:
2011.08.16
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.
